Enhanced Sensitivity to IL-2 Signaling Regulates the Clinical Responsiveness of IL-12–Primed CD8+ T Cells in a Melanoma Model
Dominique N. Lisiero(University of California, Los Angeles), Robert M. Prins(University of California, Los Angeles)
Cited by 25
Related Papers
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma
|Nature Communications|2021|257
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
|Signal Transduction and Targeted Therapy|2023|76
Enhancing adoptive T cell transfer therapies: Novel treatments through IL-12 CD8 T cell priming and adjunctive use of a histone deacetylase inhibitor
|eScholarship (California Digital Library)|2012|0